Researchers have found a biomarker that provides an early indication of whether a patient is responding to chemo-immunotherapy.

Beckman Coulter Diagnostics announced on Tuesday that it has entered a strategic partnership with Israeli diagnostic company MeMed to develop and commercialize a host immune response diagnostic test.

PerkinElmer subsidiary Oxford Immunotec said Thursday it gained US Food and Drug Administration approval for its T-Cell Select reagent kit that automates sample preparation steps for its tuberculosis in vitro diagnostic assay.

ImmunoScape, a Singapore-based developer of immune profiling technologies, said on Tuesday that it has raised $14 million in new funding.

On March 26, Beckman Coulter and Biolihe held a grand strategic cooperation signing ceremony in the cloud.

One of the most promising avenues in treating cancer is to restore our immune system’s ability to recognize and attack cancerous cells.

Scientists have identified unique “indicators” in the blood of patients with severe and fatal COVID, paving the way for simple diagnostic tests to help doctors identify who will go on to become critically ill.

Aditxt, a Richmond, VA-based biotech company, has partnered with Great Lakes Medical Laboratory (GLML) to offer the AditxtScore for COVID-19 throughout Michigan. According to the company, the test is able to assess the strength of an individual's immune response to the virus.

Research in Sri Lanka shows more than 80 per cent of those inoculated develop antibodies capable of neutralising the virus

Strains of a common subtype of influenza virus, H3N2, have almost universally acquired a mutation that effectively blocks antibodies from binding to a key viral protein.